Short William R, Lowenthal Elizabeth D, Momplaisir Florence, Powis Kathleen M, Scott Rachel K, Yee Lynn M, Miller Emily S, Mofenson Lynne M
Department of Medicine, Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, 3801 Filbert St, Suite 103B, Philadelphia, PA, 19104, USA.
Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Curr HIV/AIDS Rep. 2025 Jun 7;22(1):36. doi: 10.1007/s11904-025-00745-0.
The objective of this review is to examine the intersection of pregnancy and HIV, focusing on birthing person and fetal health outcomes, prevention of perinatal HIV transmission, and the latest advancements in treatment and care in the United States. It highlights current guidelines, challenges in management, and future directions for improving outcomes.
HIV treatment guidelines continue to highlight key principles for the choice of antiretroviral therapy in pregnancy, challenges, and strategies for adherence support. Guidelines have been updated to reflect patient-centered counseling to support shared decision making about infant feeding. Counseling should begin prior to pregnancy, and be reviewed throughout pregnancy, again at delivery, and throughout the periods when breast/chestfeeding occurs. ART use during pregnancy has significantly reduced perinatal HIV transmission. Ongoing research and collaboration are vital to addressing remaining challenges. Prioritizing maternal and infant health ensures that ART not only prevents transmission but also improves future health for families affected by HIV.
本综述的目的是探讨妊娠与艾滋病毒的交叉问题,重点关注产妇和胎儿的健康结局、围产期艾滋病毒传播的预防以及美国治疗和护理的最新进展。它强调了当前的指南、管理中的挑战以及改善结局的未来方向。
艾滋病毒治疗指南继续强调妊娠期间抗逆转录病毒疗法选择的关键原则、挑战以及坚持治疗支持的策略。指南已更新,以反映以患者为中心的咨询,以支持关于婴儿喂养的共同决策。咨询应在怀孕前开始,并在整个孕期、分娩时以及母乳喂养期间进行复查。孕期使用抗逆转录病毒疗法已显著降低围产期艾滋病毒传播。持续的研究与合作对于应对剩余挑战至关重要。优先考虑母婴健康可确保抗逆转录病毒疗法不仅能预防传播,还能改善受艾滋病毒影响家庭的未来健康状况。